These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5935446)

  • 1. Comparison of the BCG vaccine produced in Poland and BCG vaccines produced from BCG substrains of various origin.
    Buraczewska M; Kurylowicz W; Paklerska-Pobratyn H
    Pol Med J; 1966; 5(1):95-102. PubMed ID: 5935446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative laboratory evaluation of the protective properties of French and Braziliam BCG substrains and of vaccines produced from these strains in Poland].
    Szulkin E
    Med Dosw Mikrobiol; 1966; 18(4):345-52. PubMed ID: 5334256
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARISON OF BCG VACCINES PRODUCED IN POLAND WITH BCG VACCINES PREPARED FROM BCG SUBSTRAINS OF VARIOUS ORIGINS].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():781-8. PubMed ID: 14249995
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory characteristics of BCG vaccine (from Brasilian and French substrains) produced in Poland and of the original Soviet vaccine].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Pediatr Pol; 1969 Dec; 44(12):1469-76. PubMed ID: 5371124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of biological properties of BCG vaccines used in Poland 1964-1968].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1969 Oct; 37(10):901-6. PubMed ID: 5366981
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests].
    Janaszek W
    Przegl Epidemiol; 1994; 48(3):285-92. PubMed ID: 7938633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory studies on the Russian BCG vaccine and comparison with th Polish vaccine prepared from the Brazilian substrain].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1967 Jul; 35(7):609-18. PubMed ID: 6078562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protective value of the BCG vaccine use in general antituberculosis vaccination in Poland according to laboratory studies].
    Buraczewska M; Paklerska-Pobratyn H; Pichula K
    Gruzlica; 1966 Jul; 34(7):685-7. PubMed ID: 5955829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Examination of protein MPB 70 properties in BCG substrains used for the production of Polish antituberculosis vaccines].
    Janaszek W; Wysokińska T; Aleksandrowicz J
    Med Dosw Mikrobiol; 1998; 50(1-2):47-54. PubMed ID: 9857613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of 5 BCG substrains. 3. Anti-tuberculous resistance acquired by BCG vaccination with 5 vaccines of different origins].
    Paraschivesco M; Gheorghiu M; Bonciu C; Petrovici M; Rîmniceanu I
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):545-8. PubMed ID: 5400045
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the morphology of colonies of bacilli of BCG-Poland substrain. I. The influence of iron on the type of BCG-Poland colonies.
    Lipińska R; Rzucidło L
    Acta Microbiol Pol; 1978; 27(3):267-76. PubMed ID: 81600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the French and Brazilian BCG substrains and lyophilized vaccines].
    Buraczewska M; Chodkowska S; Janowiec M; Kostrzeński W; Manowska W; Paklerska-Pobratyn H; Pichula K; Tuszyńska-Pelczarska B
    Gruzlica; 1966 Jun; 34(6):513-24. PubMed ID: 5336366
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza vaccine response following its simultaneous application with BCG 1st report.
    Zykov MP; Raphaelskaya TI
    Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on BCG vaccination in respiratory tract, with special reference to a comparison with other vaccination methods. 1. Emphasis on the fate of BCG vaccine in vaccinated animals].
    Miyajima H
    Nihon Shonika Gakkai Zasshi; 1965 Jul; 69(7):627-31. PubMed ID: 5894385
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test".
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Pol Med J; 1969; 8(5):1136-42. PubMed ID: 4245977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins].
    Janaszek W
    Med Dosw Mikrobiol; 1983; 35(2):97-105. PubMed ID: 6369043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies of 5 BCG substrains. IV. Development of hemagglutinating antibodies in rabbits vaccinated with BCG vaccines of different origins].
    Gheorghiu M; Paraschivesco M
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):549-55. PubMed ID: 5400046
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"].
    Buraczewska M; Chodkowska S; Paklerska-Pobratyn H
    Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.